Tritium labelling of dopaminergic ligands domperidone and (+/−)-7-hydroxy DPAT

Methods are presented for tritiating the D2 specific dopaminergic antagonist domperidone and D3 specific dopaminergic agonist (+/−)-7-hydroxy DPAT. Techniques to characterize the products of the tritiation are also given.